First Foundation Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.39M | Buy |
120,712
+385
| +0.3% | +$10.3K | 0.14% | 104 |
|
|
2025
Q4 | $3M | Sell |
120,327
-57,190
| -32% | -$1.44M | 0.11% | 114 |
|
|
2025
Q3 | $4.52M | Sell |
177,517
-252
| -0.1% | -$6.22K | 0.17% | 90 |
|
|
2025
Q2 | $4.31M | Sell |
177,769
-7,066
| -4% | -$165K | 0.16% | 94 |
|
|
2025
Q1 | $4.68M | Sell |
184,835
-4,189
| -2% | -$110K | 0.19% | 85 |
|
|
2024
Q4 | $5.01M | Sell |
189,024
-13,913
| -7% | -$377K | 0.19% | 85 |
|
|
2024
Q3 | $5.87M | Buy |
202,937
+28,245
| +16% | +$824K | 0.22% | 72 |
|
|
2024
Q2 | $4.89M | Buy |
174,692
+18,741
| +12% | +$516K | 0.19% | 76 |
|
|
2024
Q1 | $4.33M | Buy |
155,951
+20,670
| +15% | +$574K | 0.17% | 77 |
|
|
2023
Q4 | $3.89M | Sell |
135,281
-35,671
| -21% | -$1.08M | 0.18% | 78 |
|
|
2023
Q3 | $5.67M | Buy |
170,952
+10,415
| +6% | +$368K | 0.26% | 73 |
|
|
2023
Q2 | $5.89M | Buy |
160,537
+16,553
| +11% | +$644K | 0.25% | 76 |
|
|
2023
Q1 | $5.87M | Buy |
143,984
+1,765
| +1% | +$76.2K | 0.27% | 72 |
|
|
2022
Q4 | $7.29M | Sell |
142,219
-10,070
| -7% | -$483K | 0.35% | 66 |
|
|
2022
Q3 | $6.66M | Sell |
152,289
-3,322
| -2% | -$161K | 0.33% | 64 |
|
|
2022
Q2 | $8.16M | Sell |
155,611
-4,816
| -3% | -$245K | 0.36% | 55 |
|
|
2022
Q1 | $8.3M | Sell |
160,427
-5,166
| -3% | -$268K | 0.3% | 65 |
|
|
2021
Q4 | $9.78M | Sell |
165,593
-4,160
| -2% | -$206K | 0.34% | 62 |
|
|
2021
Q3 | $7.3M | Sell |
169,753
-20,752
| -11% | -$919K | 0.27% | 70 |
|
|
2021
Q2 | $7.46M | Sell |
190,505
-431,754
| -69% | -$16.8M | 0.29% | 69 |
|
|
2021
Q1 | $22.5M | Sell |
622,259
-8,314
| -1% | -$295K | 0.97% | 23 |
|
|
2020
Q4 | $23.2M | Sell |
630,573
-21,917
| -3% | -$804K | 1.03% | 24 |
|
|
2020
Q3 | $22.7M | Sell |
652,490
-31,373
| -5% | -$1.1M | 1.05% | 19 |
|
|
2020
Q2 | $21.2M | Sell |
683,863
-19,001
| -3% | -$646K | 1.09% | 17 |
|
|
2020
Q1 | $21.8M | Sell |
702,864
-8,312
| -1% | -$283K | 1.33% | 16 |
|
|
2019
Q4 | $26.4M | Sell |
711,176
-112,449
| -14% | -$4.01M | 1.31% | 15 |
|
|
2019
Q3 | $28.1M | Buy |
823,625
+17,439
| +2% | +$634K | 1.5% | 13 |
|
|
2019
Q2 | $33.1M | Sell |
806,186
-11,468
| -1% | -$455K | 1.86% | 10 |
|
|
2019
Q1 | $32.9M | Sell |
817,654
-41,220
| -5% | -$1.65M | 1.95% | 10 |
|
|
2018
Q4 | $35.6M | Sell |
858,874
-32,986
| -4% | -$1.37M | 2.25% | 8 |
|
|
2018
Q3 | $37.3M | Sell |
891,860
-30,742
| -3% | -$1.18M | 2.06% | 10 |
|
|
2018
Q2 | $31.8M | Sell |
922,602
-127,084
| -12% | -$4.34M | 1.87% | 13 |
|
|
2018
Q1 | $35.3M | Sell |
1,049,686
-4,540
| -0.4% | -$156K | 1.97% | 14 |
|
|
2017
Q4 | $36.2M | Buy |
1,054,226
+15,370
| +1% | +$524K | 1.96% | 12 |
|
|
2017
Q3 | $35.2M | Sell |
1,038,856
-533,567
| -34% | -$17.1M | 2% | 14 |
|
|
2017
Q2 | $50.1M | Buy |
1,572,423
+54,781
| +4% | +$1.73M | 2.95% | 5 |
|
|
2017
Q1 | $49.3M | Buy |
1,517,642
+41,914
| +3% | +$1.32M | 3.05% | 4 |
|
|
2016
Q4 | $45.5M | Buy |
1,475,728
+17,935
| +1% | +$548K | 2.98% | 4 |
|
|
2016
Q3 | $46.8M | Sell |
1,457,793
-47,826
| -3% | -$1.6M | 3.24% | 4 |
|
|
2016
Q2 | $50.3M | Sell |
1,505,619
-85,730
| -5% | -$2.74M | 3.61% | 3 |
|
|
2016
Q1 | $44.8M | Buy |
1,591,349
+503,341
| +46% | +$14.4M | 3.25% | 4 |
|
|
2015
Q4 | $33.3M | Buy |
1,088,008
+68,699
| +7% | +$2.16M | 2.28% | 6 |
|
|
2015
Q3 | $30.4M | Buy |
1,019,309
+170,546
| +20% | +$5.47M | 2.49% | 6 |
|
|
2015
Q2 | $27M | Buy |
848,763
+20,341
| +2% | +$663K | 2.15% | 10 |
|
|
2015
Q1 | $27.3M | Buy |
828,422
+162,708
| +24% | +$5.17M | 2.29% | 10 |
|
|
2014
Q4 | $19.7M | Buy |
665,714
+543,414
| +444% | +$15.6M | 1.73% | 19 |
|
|
2014
Q3 | $3.43M | Buy |
122,300
+537
| +0.4% | +$15.1K | 0.34% | 46 |
|
|
2014
Q2 | $3.43M | Sell |
121,763
-8,984
| -7% | -$256K | 0.37% | 44 |
|
|
2014
Q1 | $3.98M | Sell |
130,747
-340
| -0.3% | -$10.1K | 0.49% | 41 |
|
|
2013
Q4 | $3.81M | Buy |
131,087
+2,039
| +2% | +$59.3K | 0.51% | 40 |
|
|
2013
Q3 | $3.52M | Buy |
129,048
+5,631
| +5% | +$153K | 0.55% | 39 |
|
|
2013
Q2 | $3.28M | Buy |
+123,417
| New | +$3.41M | 0.64% | 36 |
|
Other funds holding PFE
VCM
VPM
First Foundation Advisors's PFE Position: Q1 2026 in Review
First Foundation Advisors increased its Pfizer (PFE) stake by 0.32% in Q1 2026, buying an estimated $10.3K and bringing the position to 120,712 shares worth $3.39M. The position accounts for 0.14% of the portfolio, ranked #104.
First Foundation Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $50.3M in Q2 2016. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- First Foundation Advisors held 120,712 shares of Pfizer worth $3.39M as of Q1 2026.
- First Foundation Advisors bought 385 Pfizer shares in Q1 2026, an estimated $10.3K.
- Pfizer made up 0.14% of First Foundation Advisors's portfolio in Q1 2026, its #104 holding.
- First Foundation Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- First Foundation Advisors's Pfizer position peaked at $50.3M in Q2 2016.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on First Foundation Advisors's 13F filing for Q1 2026, filed 4 May 2026.